Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 6, 2008
Prevalence, treatment, and control of hypertension in residents of skilled nursing facilitiesKelli L Coover, Ann Ryan-Haddad, Michele A Faulkner, et al.Pharmacotherapy|April 22, 2004
Fingernail clubbing and chromonychia associated with the use of angiotensin II receptor blockersKathleen A Packard, Amy J Arouni, Daniel E Hilleman, et al.Current Medical Research and Opinion|September 19, 2003
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgeryDaniel E Hilleman, Antonio P Reyes, Aryan N Mooss, et al.Vascular Health and Risk Management|February 24, 2007
Optimal lipid modification: the rationale for combination therapyJames M Backes, Cheryl A Gibson, Patricia A HowardThe Annals of Pharmacotherapy|January 27, 2004
Role of C-reactive protein in cardiovascular diseaseJames M Backes, Patricia A Howard, Patrick M MoriartyPostgraduate Medicine|April 9, 2011
Important considerations for treatment with dietary supplement versus prescription niacin productsJames M Backes, Robert J Padley, Patrick M MoriartyExpert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Nesiritide for heart failure: impact on costs and complicationsClaire B Hunter, Francis Ndemo, Thomas L Lenz, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2022
Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazideKhalid Bashir, Tammy Burns, Samuel J Pirruccello, et al.Journal of Clinical Lipidology|September 27, 2012
Pseudohypertriglyceridemia: two cases of probable glycerol kinase deficiencyJames M Backes, Thomas Dayspring, Thomas Mieras, et al.The American Journal of Emergency Medicine|September 13, 2011
A systematic review of nicardipine vs labetalol for the management of hypertensive crisesW Frank Peacock, Daniel E Hilleman, Phillip D Levy, et al.Pageof 10